rwe/__init__.py,sha256=47DEQpj8HBSa-_TImW-5JCeuQeRkm5NMpJWZG3hSuFU,0
rwe/generate_report.py,sha256=vnJ-vLBzdGmeaTyNobfBth2V_8UaTwhCg28oemRh4ew,4623
rwe/assets/Arrowhead_Pharmaceuticals_logo.png,sha256=C2mAn6GG4gArds4sBnqM5LcxhuZgujXjwGiZxIuxbLo,51053
rwe/assets/Clingen-Dosage-Sensitivity-2026-04-01.csv,sha256=r3vNZDECrrSFib8okflmsxRn3N3JKP8ohcsd3cB_g5M,320033
rwe/assets/Clingen-Gene-Disease-Summary-2026-04-02.csv,sha256=jofxny8arfBUiB7hlH3_uZn-XtY2eOdpHKVWxfz80GU,1071042
rwe/assets/Combined_plof_summary_Gnomad_GeneBass_Guo_2026.csv,sha256=1FbAZlxI-mI4vSkm5NFITXjmhGTcLPWnX46tu4w4GfU,1408136
rwe/assets/ICD_to_Phecode_mapping.csv,sha256=vLHj8o5d1ffJPukUrG1NDwBKFwqhXU82JQIqoHrFF8A,12249111
rwe/assets/RWE_template.pptx,sha256=4TKCtf5lyBXbqrr9P-LLqSZZ3Z5w5Py85OmGVzN786E,345073
rwe/assets/RWE_template_general.pptx,sha256=1hyE7fbNcdHyN_2JquqEw82xLAydlY1RvZFrhit5JH8,958747
rwe/assets/RWE_template_participant_level_aou.pptx,sha256=cTUcBq84mNVneb63Yj3VYit4z4csBUq4mGiWxwUu6sQ,1918209
rwe/assets/nsamples_ptv_gene.csv.gz,sha256=aZvmAI9ihang3pjxCJAgUqBHxjzgTvo55bJomis2pKk,126086
rwe/assets/phecodeX_R_labels.csv,sha256=fKCQ-FKO_d3Yp9Ku1Vz9O6c5pP_9ikVjKowxpYffrYQ,251654
rwe/assets/phecodeX_R_map.csv,sha256=vEvRkqtHUMBAPL42BraKsyymN_8tKfqUtOxMPggFefA,2392964
rwe/clients/__init__.py,sha256=47DEQpj8HBSa-_TImW-5JCeuQeRkm5NMpJWZG3hSuFU,0
rwe/clients/aou.py,sha256=XGVi7JDZpuaEjasEBZkYn2GTc9AFgkDsMj3BpZIRK6g,26700
rwe/clients/azn.py,sha256=TCcDKLLjxzdbULfXFBaY4sstL3GOD5-tXhjshCqKgHg,13553
rwe/clients/clingen.py,sha256=9JZQ8DfypHJe7OBHH7Fp-81MzkW0KoNGG3Mcm8C2VvI,4674
rwe/clients/genebass.py,sha256=StAfZpleR7BHMKaqXsZc4YYmBD35vtv-8Nk-7is0r1E,14535
rwe/clients/gnomad.py,sha256=QxdSCZzXfkxHTDJy4vqzazevJVklSd9St6t_f9Ekkf4,4829
rwe/clients/hgnc.py,sha256=OHOUzEqRbMZaO1ddvvC3p4G5OBGgRWq4cJ5wDDFcQyI,2123
rwe/parsers/__init__.py,sha256=47DEQpj8HBSa-_TImW-5JCeuQeRkm5NMpJWZG3hSuFU,0
rwe/parsers/aou/__init__.py,sha256=47DEQpj8HBSa-_TImW-5JCeuQeRkm5NMpJWZG3hSuFU,0
rwe/parsers/aou/config.py,sha256=Np9KgbR7NT64D5OMYpmLXp5Mo2wgD2oqWuNT59VEOFo,9495
rwe/plots/__init__.py,sha256=47DEQpj8HBSa-_TImW-5JCeuQeRkm5NMpJWZG3hSuFU,0
rwe/plots/clinical.py,sha256=dBgdrFog-4gWJyJphoObSuoPtS7Q4wOprWyXMcDD6Dw,7738
rwe/plots/demographics.py,sha256=TqYY0dxroLAq9YOZHo1-SebacvNZpQjzUSui-nBUKSg,7287
rwe/plots/measurements.py,sha256=obBdbDmf1gMhRvJAzBWYbvkQW_3ho5GrfqBxrn9HQDM,3287
rwe/plots/surveys.py,sha256=2SiNBnjLQL2V4jfeMTIj2y2v7y7Wh4kLji2dnEJ0cdo,6672
rwe/plots/variant_info.py,sha256=s5DKILQoE8lx1zCt8vcThphfUJz46VXrHvJ_DHUCLGU,3945
rwe/utils/__init__.py,sha256=47DEQpj8HBSa-_TImW-5JCeuQeRkm5NMpJWZG3hSuFU,0
rwe/utils/helpers.py,sha256=7FfrAYFn0WI1aNCZZFu2VXvEZwF4DlYwFGlGxWPSkXM,7736
rwe/utils/keywords.py,sha256=lhGzMhFhaYJ1wiCzPoae_iT2SigPsxlg7gZvRAp74Cc,15129
rwe/utils/presentation.py,sha256=h7j9xHWrK3Q6iToUc_G0M1KwgfQl0DZDD1J-bcewrWo,14138
rwe/utils/report.py,sha256=buX46QeQOSZk08iPoiNPSW1QUrWFFhUrAPeqlhmFSs4,8496
rwe-0.1.2.dist-info/licenses/LICENSE,sha256=0PfJPAoyFVWY4L80aEcQyjy4PojxzfqcOenSuXdhgBg,1072
rwe-0.1.2.dist-info/METADATA,sha256=mmNQNUmGpK4v1-mAIgM0bVbp-7aeCUPMay4wRxQQtE4,7915
rwe-0.1.2.dist-info/WHEEL,sha256=aeYiig01lYGDzBgS8HxWXOg3uV61G9ijOsup-k9o1sk,91
rwe-0.1.2.dist-info/top_level.txt,sha256=zwX0M3dfnEfklZqvvBPQXiJykChpiqt219EolC3WFRc,4
rwe-0.1.2.dist-info/RECORD,,
